Securian Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$298K Sell
4,132
-100
-2% -$5.4K 0.01% 838
2026
Q1
$221K Hold
4,232
0.01% 870
2025
Q4
$249K Sell
4,232
-3,213
-43% -$195K 0.01% 859
2025
Q3
$414K Sell
7,445
-655
-8% -$35.1K 0.01% 761
2025
Q2
$417K Sell
8,100
-200
-2% -$10.1K 0.01% 748
2025
Q1
$487K Sell
8,300
-200
-2% -$13.6K 0.01% 686
2024
Q4
$612K Sell
8,500
-83
-1% -$6.09K 0.02% 606
2024
Q3
$686K Sell
8,583
-400
-4% -$30.1K 0.02% 573
2024
Q2
$644K Sell
8,983
-212
-2% -$15.6K 0.02% 577
2024
Q1
$647K Sell
9,195
-761
-8% -$54.5K 0.02% 602
2023
Q4
$768K Sell
9,956
-1,296
-12% -$85.4K 0.02% 516
2023
Q3
$766K Sell
11,252
-1,464
-12% -$116K 0.02% 503
2023
Q2
$1.04M Sell
12,716
-200
-2% -$16.1K 0.03% 459
2023
Q1
$958K Sell
12,916
-100
-0.8% -$7.71K 0.03% 479
2022
Q4
$1.08M Sell
13,016
-504
-4% -$40K 0.03% 444
2022
Q3
$960K Hold
13,520
0.03% 454
2022
Q2
$1.17M Hold
13,520
0.03% 467
2022
Q1
$1.46M Hold
13,520
0.03% 464
2021
Q4
$1.75M Hold
13,520
0.03% 439
2021
Q3
$1.64M Sell
13,520
-780
-5% -$94.9K 0.03% 442
2021
Q2
$1.61M Sell
14,300
-676
-5% -$71.2K 0.03% 446
2021
Q1
$1.43M Buy
14,976
+400
+3% +$36.5K 0.03% 461
2020
Q4
$1.16M Sell
14,576
-400
-3% -$29K 0.03% 500
2020
Q3
$928K Sell
14,976
-420
-3% -$27.3K 0.02% 541
2020
Q2
$1.02M Sell
15,396
-400
-3% -$24K 0.03% 489
2020
Q1
$749K Hold
15,796
0.02% 530
2019
Q4
$867K Sell
15,796
-1,292
-8% -$67.8K 0.02% 606
2019
Q3
$836K Sell
17,088
-1,272
-7% -$63.8K 0.02% 607
2019
Q2
$957K Sell
18,360
-96
-0.5% -$4.84K 0.02% 577
2019
Q1
$916K Hold
18,456
0.02% 576
2018
Q4
$668K Hold
18,456
0.02% 638
2018
Q3
$942K Sell
18,456
-400
-2% -$17.7K 0.02% 589
2018
Q2
$697K Buy
18,856
+400
+2% +$15.3K 0.02% 664
2018
Q1
$697K Hold
18,456
0.02% 669
2017
Q4
$598K Sell
18,456
-652
-3% -$20.7K 0.01% 728
2017
Q3
$577K Buy
19,108
+400
+2% +$11.9K 0.02% 703
2017
Q2
$550K Sell
18,708
-400
-2% -$10.9K 0.01% 710
2017
Q1
$486K Buy
19,108
+560
+3% +$14.5K 0.01% 754
2016
Q4
$477K Buy
18,548
+520
+3% +$13.7K 0.01% 755
2016
Q3
$494K Hold
18,028
0.01% 710
2016
Q2
$508K Sell
18,028
-2,024
-10% -$52K 0.01% 684
2016
Q1
$474K Buy
20,052
+552
+3% +$12.2K 0.01% 728
2015
Q4
$439K Sell
19,500
-1,004
-5% -$22.9K 0.01% 748
2015
Q3
$474K Sell
20,504
-400
-2% -$10K 0.02% 721
2015
Q2
$515K Hold
20,904
0.02% 742
2015
Q1
$524K Hold
20,904
0.02% 752
2014
Q4
$483K Hold
20,904
0.01% 760
2014
Q3
$489K Buy
20,904
+2,356
+13% +$55.2K 0.02% 739
2014
Q2
$429K Sell
18,548
-800
-4% -$17.7K 0.01% 793
2014
Q1
$413K Hold
19,348
0.02% 772
2013
Q4
$458K Sell
19,348
-400
-2% -$8.67K 0.02% 746
2013
Q3
$395K Sell
19,748
-1,172
-6% -$22.2K 0.02% 763
2013
Q2
$361K Buy
+20,920
New +$347K 0.01% 769

Other funds holding TECH

Securian Asset Management's TECH Position: Q2 2026 in Review

Securian Asset Management reduced its Bio-Techne (TECH) stake by 2.4% in Q2 2026, selling an estimated $5.4K and leaving 4,132 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #838.

Securian Asset Management first reported a position in TECH in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.75M in Q4 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Securian Asset Management held 4,132 shares of Bio-Techne worth $298K as of Q2 2026.
  • Securian Asset Management sold 100 Bio-Techne shares in Q2 2026, an estimated $5.4K.
  • Bio-Techne made up 0.01% of Securian Asset Management's portfolio in Q2 2026, its #838 holding.
  • Securian Asset Management first reported a position in Bio-Techne in Q2 2013 and has held it in 53 quarters since.
  • Securian Asset Management's Bio-Techne position peaked at $1.75M in Q4 2021.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.